Chemistry Wealth Management LLC increased its stake in shares of Salesforce Inc. (NYSE:CRM – Free Report) by 62.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,155 shares of the CRM provider’s stock after acquiring an additional 5,063 shares during the period. Chemistry Wealth Management LLC’s holdings in Salesforce were worth $2,061,000 as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC lifted its stake in shares of Salesforce by 13.7% during the 4th quarter. Brighton Jones LLC now owns 25,668 shares of the CRM provider’s stock worth $8,582,000 after buying an additional 3,102 shares during the last quarter. Revolve Wealth Partners LLC grew its stake in shares of Salesforce by 12.6% in the fourth quarter. Revolve Wealth Partners LLC now owns 1,827 shares of the CRM provider’s stock valued at $611,000 after acquiring an additional 205 shares in the last quarter. Bison Wealth LLC boosted its holdings in Salesforce by 9.0% in the 4th quarter. Bison Wealth LLC now owns 2,234 shares of the CRM provider’s stock valued at $747,000 after purchasing an additional 184 shares during the period. Sivia Capital Partners LLC boosted its stake in shares of Salesforce by 3.7% in the second quarter. Sivia Capital Partners LLC now owns 2,958 shares of the CRM provider’s stock valued at $807,000 after buying an additional 106 shares during the period. Finally, United Bank raised its holdings in Salesforce by 5.2% in the 2nd quarter. United Bank now owns 10,198 shares of the CRM provider’s stock valued at $2,781,000 after acquiring an additional 500 shares in the last quarter. Institutional investors and hedge funds own 80.43% of the company’s stock.
Analysts Set New Price Targets
CRM has been the topic of several recent analyst reports. Piper Sandler lowered shares of Salesforce from an “overweight” rating to a “neutral” rating in a report on Thursday, May 28th. BMO Capital Markets decreased their price target on shares of Salesforce from $225.00 to $215.00 and set an “outperform” rating on the stock in a report on Thursday, May 28th. Guggenheim upgraded Salesforce from a “neutral” rating to a “buy” rating and set a $228.00 price target for the company in a research note on Wednesday, July 1st. Barclays raised Salesforce from an “overweight” rating to an “overweight” rating in a research note on Thursday, June 18th. Finally, Citizens Jmp restated a “market outperform” rating and issued a $315.00 price objective on shares of Salesforce in a report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, sixteen have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $249.51.
Ad Profits Run
Your book attached
Bill Poulos is giving away his ‘Safe Trade Options Formula’ book for free – but only for a limited time through a temporary download link.nnHe plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.
Download the Safe Trade Options Formula book for free before access closes
